259 related articles for article (PubMed ID: 16396251)
1. Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Howell A; Midturi J; Sierra-Hoffman M; Carpenter J; Hurley D; Winn R
Med Mycol; 2005 Nov; 43(7):651-5. PubMed ID: 16396251
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
Fincher T; Fulcher SF
Cornea; 2007 Jun; 26(5):618-20. PubMed ID: 17525663
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection.
Kim JE; Perkins SL; Harris GJ
Arch Ophthalmol; 2003 May; 121(5):735-7. PubMed ID: 12742860
[No Abstract] [Full Text] [Related]
4. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D
Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298
[TBL] [Abstract][Full Text] [Related]
5. Successful antifungal combination therapy with voriconazole and caspofungin.
Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
Durand ML; Kim IK; D'Amico DJ; Loewenstein JI; Tobin EH; Kieval SJ; Martin SS; Azar DT; Miller FS; Lujan BJ; Miller JW
Am J Ophthalmol; 2005 Sep; 140(3):552-4. PubMed ID: 16139017
[TBL] [Abstract][Full Text] [Related]
7. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
Warn PA; Sharp A; Mosquera J; Spickermann J; Schmitt-Hoffmann A; Heep M; Denning DW
J Antimicrob Chemother; 2006 Dec; 58(6):1198-207. PubMed ID: 17071636
[TBL] [Abstract][Full Text] [Related]
9. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
10. Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Bonatti H; Lass-Floerl C; Angerer K; Singh N; Lechner M; Stelzmueller I; Singh R; Schmid T; Geltner C
Mycoses; 2010 Sep; 53(5):448-54. PubMed ID: 19496935
[TBL] [Abstract][Full Text] [Related]
11. [Efficacies and clinical roles of new antifungal agents].
Tokimatsu I; Kadota J
Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):155-9. PubMed ID: 16940948
[TBL] [Abstract][Full Text] [Related]
12. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
13. Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
Tsiodras S; Zafiropoulou R; Giotakis J; Imbrios G; Antoniades A; Manesis EK
Transpl Infect Dis; 2004 Mar; 6(1):37-40. PubMed ID: 15225226
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
[TBL] [Abstract][Full Text] [Related]
15. Combination antifungal therapy for invasive aspergillosis.
Marr KA; Boeckh M; Carter RA; Kim HW; Corey L
Clin Infect Dis; 2004 Sep; 39(6):797-802. PubMed ID: 15472810
[TBL] [Abstract][Full Text] [Related]
16. Multi-azole resistance in Aspergillus fumigatus.
Howard SJ; Webster I; Moore CB; Gardiner RE; Park S; Perlin DS; Denning DW
Int J Antimicrob Agents; 2006 Nov; 28(5):450-3. PubMed ID: 17034993
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
MacCallum DM; Whyte JA; Odds FC
Antimicrob Agents Chemother; 2005 Sep; 49(9):3697-701. PubMed ID: 16127042
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
Chirch L; Roche P; Fuhrer J
Ear Nose Throat J; 2008 Jan; 87(1):30-3. PubMed ID: 18357943
[TBL] [Abstract][Full Text] [Related]
19. Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection.
Cacciapuoti A; Halpern J; Mendrick C; Norris C; Patel R; Loebenberg D
Antimicrob Agents Chemother; 2006 Jul; 50(7):2587-90. PubMed ID: 16801452
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
Domínguez-Gil A; Martín I; García Vargas M; Del Castillo A; Díaz S; Sánchez C
Clin Drug Investig; 2007; 27(3):197-205. PubMed ID: 17305414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
